Enzon Pharmaceuticals Statistics

Total Valuation

BST:EZ1 has a market cap or net worth of EUR 7.25 million. The enterprise value is 5.59 million.

Market Cap	7.25M
Enterprise Value	5.59M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.21M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	30.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	301.39
PB Ratio	0.17
P/TBV Ratio	4.01
P/FCF Ratio	n/a
P/OCF Ratio	30.97
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.51
EV / Sales	252.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 82.17

Current Ratio	82.17
Quick Ratio	81.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -0.14% and return on invested capital (ROIC) is -2.74%.

Return on Equity (ROE)	-0.14%
Return on Assets (ROA)	-2.71%
Return on Invested Capital (ROIC)	-2.74%
Return on Capital Employed (ROCE)	-4.45%
Revenue Per Employee	24,055
Profits Per Employee	-1.24M
Employee Count	1
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, BST:EZ1 has paid 337,698 in taxes.

Income Tax	337,698
Effective Tax Rate	122.07%

Stock Price Statistics

The stock price has decreased by -37.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.60%
50-Day Moving Average	0.07
200-Day Moving Average	0.08
Relative Strength Index (RSI)	53.41
Average Volume (20 Days)	953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.07

Income Statement

In the last 12 months, BST:EZ1 had revenue of EUR 24,055 and -1.24 million in losses. Loss per share was -0.02.

Revenue	24,055
Gross Profit	24,055
Operating Income	-1.85M
Pretax Income	276,635
Net Income	-1.24M
EBITDA	n/a
EBIT	-1.85M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 41.60 million in cash and n/a in debt, giving a net cash position of 41.60 million.

Cash & Cash Equivalents	41.60M
Total Debt	n/a
Net Cash	41.60M
Net Cash Per Share	n/a
Equity (Book Value)	41.60M
Book Value Per Share	0.02
Working Capital	41.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	234,076
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -7,703.91% and -253.85%.

Gross Margin	100.00%
Operating Margin	-7,703.91%
Pretax Margin	1,150.01%
Profit Margin	-253.85%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BST:EZ1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-17.11%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:EZ1 has an Altman Z-Score of 9.04 and a Piotroski F-Score of 2.

Altman Z-Score	9.04
Piotroski F-Score	2